The DOI matches its Crossref record; 243 of the 247 references it cites were found in a registry or an index.
Inflammation and Colon Cancer
Abstract
The connection between inflammation and tumorigenesis is well-established and in the last decade has received a great deal of supporting evidence from genetic, pharmacological, and epidemiological data. Inflammatory bowel disease is an important risk factor for the development of colon cancer. Inflammation is also likely to be involved with other forms of sporadic as well as heritable colon cancer. The molecular mechanisms by which inflammation promotes cancer development are still being uncovered and could differ between colitis-associated and other forms of colorectal cancer. Recent work has elucidated the role of distinct immune cells, cytokines, and other immune mediators in virtually all steps of colon tumorigenesis, including initiation, promotion, progression, and metastasis. These mechanisms, as well as new approaches to prevention and therapy, are discussed in this review.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is evidence that a link between inflammation and colorectal cancer exists.”
From Hyaluronic a cid–doxorubicin nanoparticles for targeted treatment of colorectal cancer (2021) · cites this paper as [98]
In the citing paper
“Chronic intestinal inflammation has been associated with the development of CRC and it can result from an aberrant ratio of protective (tolerogenic) to aggressive (proinflammatory, pro-tumorigenic) microbiota [45] .”
From Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis (2014) · cites this paper as [45]
In the citing paper
“Many bacterial species were found to be enriched in colorectal tumour samples and adjacent tissue: B. fragilis, Bacteroides vulgatus, Bifidobacterium longum, Clostridium butyricum, Mitsuokella multiacida, E. coli, Enterococcus faecalis, and S. bovis [45] .”
From Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis (2014) · cites this paper as [45]
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Self-citationThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Cited by
Sorted by citations
Items 601–700 of 1,003
Morgan, D., Berggren, K. L., Spiess, C., Smith, H. M., Tejwani, A., Weir, S. J., Lominska, C. E., Thomas, S. M., & Gan, G. N. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23348 · Cited by 42
Zhu, Y., Cai, P.-J., Dai, H.-C., Xiao, Y., Jia, C., & Sun, A. (2023) · Food & Function · doi:10.1039/d3fo02177g · Cited by 44
Curcumin and its anti‐colorectal cancer potential: From mechanisms of action to autophagy
Brockmueller, A., de Porras, V. R., & Shakibaei, M. (2024) · Phytotherapy Research · doi:10.1002/ptr.8220 · Cited by 45
Serum Interleukin-6, Insulin, and HOMA-IR in Male Individuals with Colorectal Adenoma
Sasaki, Y., Takeda, H., SATO, T. A., Orii, T., Nishise, S., Nagino, K., Iwano, D., Yaoita, T., Yoshizawa, K., Saito, H., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0896 · Cited by 42
Xi, M., Jia, J.-M., Sun, H.-P., Sun, Z., Jiang, J., Wang, Y., Zhang, M., Zhu, J., Xu, L., Jiang, Z., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400944k · Cited by 42
Local and systemic Th17 immune response associated with advanced stage colon cancer
Sharp, S. P., Avram, D., Stain, S. C., & Lee, E. C. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.09.038 · Cited by 44
The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer
Uribe, D. J., Mandell, E. K., Watson, A., Martinez, J. D., Leighton, J. A., Ghosh, S., & Rothlin, C. V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179979 · Cited by 42
Sun, F., Tan, Y., Gao, Q., Li, S., Zhang, J., Chen, Q., Jiang, Y., Zhang, L., Ying, H., & Wang, X. (2018) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22635 · Cited by 40
Interleukin-33 and ST2 Signaling in Tumor Microenvironment
Hong, J., Kim, S., & Lin, P. C. (2018) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0044 · Cited by 43
Wagner, S., Vlachogiannis, G., Brandon, A. D. H., Valenti, M. R., Box, G., Jenkins, L., Mancusi, C., Self, A. J., Manodoro, F., Assiotis, I., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0554-z · Cited by 43
Zhuo, M., Chen, W., Shang, S., Guo, P., Peng, K., Li, M., Mo, P., Zhang, Y., Qiu, X., Li, W., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1219-2 · Cited by 42
Targeted Delivery of CXCL9 and OX40L by Mesenchymal Stem Cells Elicits Potent Antitumor Immunity
Yin, P., Gui, L., Wang, C., Yan, J., Liu, M., Ji, L., Wang, Y., Ma, B., & Gao, W. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.08.005 · Cited by 44
Wang, G., Hiramoto, K., Ma, N., Yoshikawa, N., Ohnishi, S., Murata, M., & Kawanishi, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052609 · Cited by 47
Dual role of heme iron in cancer; promotor of carcinogenesis and an inducer of tumour suppression
Gamage, S. M. K., Lee, K. T., Dissabandara, L., Lam, A. K.-Y., & Gopalan, V. (2021) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2021.104642 · Cited by 44
Hasegawa, T., Mizugaki, A., Inoue, Y., Kato, H., & Murakami, H. (2021) · Amino Acids · doi:10.1007/s00726-021-03001-y · Cited by 43
Hyaluronic a cid–doxorubicin nanoparticles for targeted treatment of colorectal cancer
Pan, D. C., Krishnan, V., Salinas, A. K., Kim, J., Sun, T., Ravid, S., Peng, K., Wu, D., Nurunnabi, M., Nelson, J. A., et al. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10166 · Cited by 42
Rahmati, S., Moeinafshar, A., & Rezaei, N. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05267-8 · Cited by 47
De-coding the complex role of microbial metabolites in cancer
Escriva, P. P., Bernardino, C. C. T., & Letellier, E. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115358 · Cited by 48
Zhang, Q., Zhou, D., Lei, Y., Li, Z., Chen, S., Gou, H., Gu, Q., He, X., Lan, T., Qi, C., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3060 · Cited by 41
Wang, G., Li, N., Chang, S., Bassig, B. A., Guo, L., Ren, J., Su, K., Li, F., Chen, S., Wu, S., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1112 · Cited by 41
Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis
Guo, Y., Bao, Y., & Yang, W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040890 · Cited by 41
Shivappa, N., Schneider, A. L. C., Hébert, J. R., Köenig, W., Peters, A., & Thorand, B. (2017) · European Journal of Public Health · doi:10.1093/eurpub/ckx060 · Cited by 41
Mechanisms coupling thrombin to metastasis and tumorigenesis
Remiker, A. S., & Palumbo, J. S. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2017.12.020 · Cited by 41
Mesenchymal MAPKAPK2/HSP27 drives intestinal carcinogenesis
Henriques, A. R., Koliaraki, V., & Kollias, G. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805683115 · Cited by 41
Cavalleri, T., Bianchi, P. P., Basso, G., Celesti, G., Grizzi, F., Bossi, P., Greco, L., Pitrone, C., Valtorta, E., Mauri, G., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0661 · Cited by 41
Ieda, T., Tazawa, H., Okabayashi, H., Yano, S., Shigeyasu, K., Kuroda, S., Ohara, T., Noma, K., Kishimoto, H., Nishizaki, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52816-z · Cited by 40
Li, H., Zhao, L., Lau, Y. S., Zhang, C., & Han, R. (2020) · Oncogene · doi:10.1038/s41388-020-01523-5 · Cited by 41
Zhang, H., Shi, Y., Lin, C., He, C., Wang, S., Li, Q., Sun, Y. P., & Li, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1338918 · Cited by 40
Pagnotta, S. M., Laudanna, C., Pancione, M., Sabatino, L., Votino, C., Remo, A., Cerulo, L., Zoppoli, P., Manfrin, E., Colantuoni, V., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072638 · Cited by 40
Omrane, I., Baroudi, O., Bougatef, K., Mézlini, A., Abidi, A., Medimegh, I., Stambouli, N., Ayari, H., Kourda, N., Uhrhammer, N. A., et al. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.01.002 · Cited by 40
Shibutani, M., Maeda, K., Nagahara, H., Iseki, Y., Ikeya, T., & Hirakawa, K. (2016) · Oncology Letters · doi:10.3892/ol.2016.5487 · Cited by 40
Wu, X., Lu, R., Wang, L., Wang, Y., Dai, Y., Wang, C., Yang, Y., Guo, F., Xue, J., & Yang, D. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27079 · Cited by 40
Liu, H., Lu, W., He, H., Wu, J., Zhang, C., Gong, H., & Yang, C. (2019) · The Journal of Pathology · doi:10.1002/path.5273 · Cited by 40
Sun, X. Y., Ng, T. T. H., Sham, K. W. Y., Zhang, L., Chan, M. T. V., Wu, W. K. K., & Cheng, C. H. K. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0134 · Cited by 40
Ke, Z., Wang, C., Wu, T., Wang, W., Yang, Y., & Dai, Y. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.015 · Cited by 40
Significance of the 7th postoperative day neutrophil-to-lymphocyte ratio in colorectal cancer
Hayama, T., Hashiguchi, Y., Okada, Y., Ono, K., Nemoto, K., Shimada, R., Ozawa, T., Toyoda, T., Tsuchiya, T., Iinuma, H., et al. (2019) · International Journal of Colorectal Disease · doi:10.1007/s00384-019-03463-3 · Cited by 40
Influence of Iron on the Gut Microbiota in Colorectal Cancer
Phipps, O., Al-Hassi, H. O., Quraishi, M. N., Kumar, A., & Brookes, M. (2020) · Nutrients · doi:10.3390/nu12092512 · Cited by 41
Hosseini, M. S., Baghaei, K., Hajivalili, M., Zali, M. R., Ebtekar, M., & Amani, D. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120234 · Cited by 40
C-Reactive Protein, Lipid-soluble Micronutrients, and Survival in Colorectal Cancer Patients
Cooney, R. V., Chai, W., Franke, A. A., Wilkens, L. R., Kolonel, L. N., & Marchand, L. L. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0199 · Cited by 40
Alorda-Clara, M., Torrens‐Mas, M., Morla-Barcelo, P. M., Roca, P., Sastre‐Serra, J., Pons, D. G., & Oliver, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147526 · Cited by 39
Zielinski, M. R., Davis, J. M., Fadel, J. R., & Youngstedt, S. D. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.03.002 · Cited by 39
The Laminin Response in Inflammatory Bowel Disease: Protection or Malignancy?
Spenlé, C., Lefèbvre, O., Lacroute, J., Méchine‐Neuville, A., Barreau, F., Blottière, H. M., Duclos, B., Arnold, C., Hussenet, T., Hemmerlé, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111336 · Cited by 39
Thrombin Drives Tumorigenesis in Colitis-Associated Colon Cancer
Turpin, B. K., Miller, W., Rosenfeldt, L. A., Kombrinck, K. W., Flick, M. J., Steinbrecher, K. A., Harmel-Laws, E., Mullins, E. S., Shaw, M. A., Witte, D. P., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3276 · Cited by 39
Colon Cancer Chemoprevention by Sage Tea Drinking: Decreased DNA Damage and Cell Proliferation
Pedro, D. F. N., Ramos, A. A., Lima, C. F., Baltazar, F., & Pereira‐Wilson, C. (2015) · Phytotherapy Research · doi:10.1002/ptr.5531 · Cited by 40
Bellamkonda, K., Chandrashekar, N., Osman, J., Selvanesan, B. C., Savari, S., & Sjölander, A. (2016) · BMC Cancer · doi:10.1186/s12885-016-2466-z · Cited by 39
Liu, J., Lei, L., Ye, F., Zhou, Y., Younis, H. G. R., & Zhao, G. (2017) · Food & Function · doi:10.1039/c7fo01569k · Cited by 40
Liu, H., Zeng, J., Huang, W., Xu, Q., Ye, D., Sun, R., & Zhang, D. (2019) · Journal of Cancer · doi:10.7150/jca.32456 · Cited by 39
Systemic Interleukins’ Profile in Early and Advanced Colorectal Cancer
Czajka‐Francuz, P., Cisoń-Jurek, S., Czajka, A., Kozaczka, M., Wojnar, J., Chudek, J. T., & Francuz, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010124 · Cited by 42
Sun, L., He, Z., Ke, J., Li, S., Wu, X., Lian, L., He, X., He, X., Hu, J., Zou, Y., et al. (2015) · Europe PMC (PubMed Central) · Cited by 39
Interleukin-21 in cancer immunotherapy
Stolfi, C., Pallone, F., MacDonald, T. T., & Monteleone, G. (2012) · OncoImmunology · doi:10.4161/onci.19122 · Cited by 39
Sukocheva, O. A., Неганова, М. Е., Aleksandrova, Y. R., Burcher, J. T., Chugunova, E., Fan, R., Tse, E., Sethi, G., Bishayee, A., & Liu, J. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01626-6 · Cited by 42
Feng, F., Jiang, Y., Lu, H., Lu, X., Wang, S., Wang, L., Wei, M., Lu, W., Du, Z., Ye, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11454 · Cited by 38
Gu, X., Gao, X., Qin, S., Li, X., Qi, X., Ma, M., Yu, H., Sun, S., Zhou, D., Wang, W., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163523 · Cited by 38
Seebauer, C. T., Brunner, S. M., Glockzin, G., Piso, P., Ruemmele, P., Schlitt, H. J., Geissler, E. K., Fichtner‐Feigl, S., & Kesselring, R. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1242543 · Cited by 39
Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies
Godos, J., Biondi, A., Galvano, F., Basile, F., Sciacca, S., Giovannucci, E. L., & Grosso, G. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i10.1909 · Cited by 38
Platelets contribute to the initiation of colitis‐associated cancer by promoting immunosuppression
Servais, L., Wéra, O., Epoh, J. D., Delierneux, C., Bouznad, N., Rahmouni, S., Mazzucchelli, G., Baiwir, D., Delvenne, P., Lancellotti, P., et al. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13959 · Cited by 38
miR-34a is a microRNA safeguard for Citrobacter-induced inflammatory colon oncogenesis
Wang, L., Wang, E., Wang, Y., Mines, R. C., Xiang, K., Sun, Z., Zhou, G., Chen, K., Rakhilin, N., Chao, S., et al. (2018) · eLife · doi:10.7554/elife.39479 · Cited by 39
Li, J., Lu, Y., Wang, D., Quan, F., Chen, X., Sun, R., Zhao, S., Yang, Z., Tao, W., Ding, D., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.059 · Cited by 39
Wang, H., Lu, Y., Gong, Y., & Zhang, B. (2018) · Europe PMC (PubMed Central) · Cited by 39
Song, M., Lan, Y., Wu, X., Han, Y., Wang, M., Zheng, J., Li, Z., Li, F., Zhou, J., Xiao, J., et al. (2020) · Food & Function · doi:10.1039/d0fo00616e · Cited by 38
The thrombin–inflammation axis in cancer progression
Cantrell, R., & Palumbo, J. S. (2020) · Thrombosis Research · doi:10.1016/s0049-3848(20)30408-4 · Cited by 38
All are Equal, Some are More Equal: Targeting IL 12 and 23 in IBD – A Clinical Perspective
Jefremow, A., & Neurath, M. F. (2020) · ImmunoTargets and Therapy · doi:10.2147/itt.s282466 · Cited by 38
Nowacka-Jechalke, N., Nowak, R., Lemieszek, M. K., Rzeski, W., Gawlik‐Dziki, U., Szpakowska, N., & Kaczyński, Z. (2021) · Nutrients · doi:10.3390/nu13010161 · Cited by 38
Frauches, N. S., Montenegro, J., Amaral, T., de Abreu, J. P., Pascoal, G. D. F. L., Junior, J., Borguini, R. G., Santiago, M. C. P. D. A., Pacheco, S., Nakajima, V. M., et al. (2021) · Molecules · doi:10.3390/molecules26030564 · Cited by 38
Stem Cell Impairment at the Host-Microbiota Interface in Colorectal Cancer
Marzano, M., Fosso, B., Piancone, E., Defazio, G., Pesole, G., & Robertis, M. D. (2021) · Cancers · doi:10.3390/cancers13050996 · Cited by 40
Efferocytosis in multisystem diseases (Review)
Zhang, Y., Wang, Y., Ding, J., & Liu, P. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12529 · Cited by 38
Wu-Mei-Wan Ameliorates Murine Ulcerative Colitis by Regulating Macrophage Polarization
Yan, S., Wei, H., Jia, R., Zhen, M., Bao, S., Wang, W., Liu, F., & Jingtao, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.859167 · Cited by 40
Obata‐Ninomiya, K., Carrion, S. D. J., Hu, A. K., & Ziegler, S. F. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl6960 · Cited by 37
Motamedi, H., Ari, M. M., Shahlaei, M., Moradi, S., Farhadikia, P., Alvandi, A., & Abiri, R. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05197-0 · Cited by 37
CD93 gene polymorphism is associated with disseminated colorectal cancer
Olsen, R. S., Lindh, M., Vorkapić, E., Andersson, R. E., Zar, N., Löfgren, S., Dimberg, J., Matussek, A., & Wågsäter, D. (2015) · International Journal of Colorectal Disease · doi:10.1007/s00384-015-2247-1 · Cited by 37
Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women
Song, M., Mehta, R. S., Wu, K., Fuchs, C. S., Ogino, S., Giovannucci, E. L., & Chan, A. T. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0307 · Cited by 37
Bongers, G., Muniz, L. R., Pacer, M. E., Iuga, A. C., Thirunarayanan, N., Slinger, E., Smit, M. J., Reddy, E. P., Mayer, L., Furtado, G. C., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.034 · Cited by 37
van Herk, E. H., & Velde, A. A. T. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13342 · Cited by 37
Subramaniam, R., Mizoguchi, A., & Mizoguchi, E. (2016) · Cancer Research Frontiers · doi:10.17980/2016.1 · Cited by 39
Brewers’ rice modulates oxidative stress in azoxymethane-mediated colon carcinogenesis in rats
Tan, B. L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i29.8826 · Cited by 37
Biomarkers for colitis-associated colorectal cancer
Chen, R., Lai, L. A., Brentnall, T. A., & Pan, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i35.7882 · Cited by 38
Ma, L., Chen, Q., Ma, P., Han, M. K., Xu, Z., Kang, Y., Xiao, B., & Merlin, D. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0107 · Cited by 37
STAT1 is a sex‐specific tumor suppressor in colitis‐associated colorectal cancer
Crnčec, I., Modak, M., Gordziel, C., Svinka, J., Scharf, I., Moritsch, S., Pathria, P., Schlederer, M., Kenner, L., Timelthaler, G., et al. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12178 · Cited by 35
Huang, H., Cai, B., Suen, C., Lee, H.-Y., Hwang, M., Liu, F., & Kannagi, R. (2020) · Cells · doi:10.3390/cells9020397 · Cited by 37
Multifaceted Roles of TRIM Proteins in Colorectal Carcinoma
Eberhardt, W., Haeussler, K., Nasrullah, U., & Pfeilschifter, J. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207532 · Cited by 39
A common fungicide tebuconazole promotes colitis in mice via regulating gut microbiota
Meng, Z., Sun, W., Liu, W., Wang, Y., Jia, M., Tian, S., Chen, X., Zhu, W., & Zhou, Z. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.118477 · Cited by 37
Selective terpene based therapeutic deep eutectic systems against colorectal cancer
Pereira, J., Castro, M. M., Santos, F., Duarte, A. R. C., Paiva, A., Oliveira, F., & Duarte, A. R. C. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.04.008 · Cited by 38
Hippo pathway in intestinal homeostasis and tumorigenesis
Chen, L., Qin, F., Deng, X., Avruch, J., & Zhou, D. (2012) · Protein & Cell · doi:10.1007/s13238-012-2913-9 · Cited by 42
Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring
Maryam, S., Krukiewicz, K., Haq, I. U., Khan, A. A., Yahya, G., & Cavalu, S. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093127 · Cited by 40
Unlocking the potential of flavonoids: Natural solutions in the fight against colon cancer
Hasibuan, P. A. Z., Simanjuntak, Y., Hey‐Hawkins, E., Lubis, M. F., Rohani, A. S., Park, M. N., Kim, B., & Syahputra, R. A. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116827 · Cited by 38
Huang, H.-L., Liu, C., Chou, M., Ko, C.-H., & Wang, C. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2014.3213 · Cited by 38
Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort
Swede, H., Hajduk, A. M., Sharma, J., Rawal, S., Rasool, H., Vella, A. T., Tobet, R. E., & Stevens, R. G. (2013) · International Journal of Cancer · doi:10.1002/ijc.28504 · Cited by 36
MicroRNA binding site polymorphisms as biomarkers in cancer management and research
Landi, S., Gemignani, F., & Cipollini, M. (2014) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s61693 · Cited by 36
The loss of MiR-139-5p promotes colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt signaling
Mao, R., Zou, F., Yang, L., Lin, S., Li, Y., Ma, M., Yin, P., Liang, X., & Liu, J. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.10.008 · Cited by 36
Prognostic and predictive potential molecular biomarkers in colon cancer.
Năstase, A., Pâslaru, L., Niculescu, A. M., Ionescu, M., Dumitraşcu, T., Herlea, V., Dima, S., Gheorghe, C., Lazar, V., & Popescu, I. (2011) · PubMed · Cited by 36
Low HtrA1 expression in patients with long-standing ulcerative colitis and colorectal cancer
Altobelli, E., Latella, G., Morroni, M., Licini, C., Tossetta, G., Roberta Mazzucchelli, A., Profeta, V. F., Coletti, G., Leocata, P., Castellucci, M., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5700 · Cited by 36
Koh, S., Choi, Y. I., Kim, Y., Kim, Y. S., Choi, S., Kim, J. W., Kim, B. G., & Lee, K. L. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1704-3 · Cited by 36
Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk
El-Fattah, A. A. A., Sadik, N. A. H., Shaker, O. G., & Kamal, A. M. (2018) · Mediators of Inflammation · doi:10.1155/2018/9853192 · Cited by 37
Chen, Q.-G., Zhang, L., Sun, F., Li, S., You, X.-H., Jiang, Y., Yang, W., Zhong, Q., Wang, X., & Ying, H. (2019) · Aging · doi:10.18632/aging.101864 · Cited by 37
Protective Innate Immune Variants in Racial/Ethnic Disparities of Breast and Prostate Cancer
Yeyeodu, S. T., Kidd, L. R., & Kimbro, K. S. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0564 · Cited by 36
Arnesen, H., Müller, M. H. B., Aleksandersen, M., Østby, G. C., Carlsen, H., Paulsen, J. E., & Boysen, P. (2021) · Laboratory Animal Research · doi:10.1186/s42826-021-00096-y · Cited by 36
Kargl, J., Haybaeck, J., Stančić, A., Andersen, L., Marsche, G., Heinemann, Á., & Schicho, R. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0957-1 · Cited by 37
Aggarwal, A., Prinz-Wohlgenannt, M., Gröschel, C., Tennakoon, S., Meshcheryakova, A., Chang, W., Brown, E. M., Mechtcheriakova, D., & Kállay, E. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0330-4 · Cited by 38
Campregher, C., & Gasché, C. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.10.013 · Cited by 36
Colitis-Associated and Sporadic Colon Cancers: Different Diseases, Different Mutations?
Grivennikov, S. I., & Cominelli, F. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.062 · Cited by 36
Self-citation
Metadata
- Authors
- Terzić, J., Grivennikov, S., Karin, E., & Karin, M.
- Affiliations
- University of California San Diego (US)
- Tel Aviv Sourasky Medical Center (IL)
- Corresponding author
- Karin, Michael
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 138
- Issue
- 6
- Pages
- 2101-2114.e5
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2085852125
- Cited by
- 1,974
- References
- 247
- Citations by year
- 2026: 41 · 2025: 80 · 2024: 106 · 2023: 140 · 2022: 147 · 2021: 192 · 2020: 159 · 2019: 139 · 2018: 144 · 2017: 145 · 2016: 136 · 2015: 127 · 2014: 112 · 2013: 119 · 2012: 86
- FWCI
- 10.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Crohn's and Colitis Foundation of America (1762)
- American Association for Cancer Research
- American Cancer Society
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- inflammation, colon cancer, colorectal cancer, inflammatory bowel disease, colitis-associated colorectal cancer, carcinogenesis, immune cells, cytokines, cancer prevention, cancer therapy, metastasis
- MeSH terms
- Animals, Anti-Inflammatory Agents, Cell Transformation, Neoplastic, Colon, Colonic Neoplasms, Humans, Neoplasm Invasiveness, Risk Factors, Colorectal Neoplasms, Inflammatory Bowel Diseases, Signal Transduction, Gene Expression Regulation, Neoplastic, Cytokines, Anticarcinogenic Agents, Risk Assessment, Inflammation Mediators, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review